BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1976585)

  • 1. Neurochemical control of oxyntic cell secretion.
    Black JW
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():31-5. PubMed ID: 1976585
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of gastric acid secretion at the cellular level.
    Wollin A
    Clin Invest Med; 1987 May; 10(3):209-14. PubMed ID: 2887322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects of the neural regulation of gastric acid secretion].
    Eysselein VE
    Z Gastroenterol Verh; 1987 Apr; 22():91-6. PubMed ID: 2442917
    [No Abstract]   [Full Text] [Related]  

  • 5. Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach.
    Ochi Y; Horie S; Maruyama T; Watanabe K; Yano S
    Life Sci; 2005 Sep; 77(16):2040-50. PubMed ID: 15919097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ranitidine and cimetidine on pentagastrin and insulin stimulated gastric secretion.
    Sheers R; Roberts N
    Scand J Gastroenterol Suppl; 1981 Jun; 69():51-9. PubMed ID: 6119783
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
    Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular mechanism of gastric acid secretion and mode of action of inhibiting drugs].
    Lewin M
    Rev Med Suisse Romande; 1995 Oct; 115(10):767-72. PubMed ID: 7501928
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat.
    Kato S; Aihara E; Yoshii K; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G64-9. PubMed ID: 15961884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Stables R; Humphray JM; Reeves JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogenesis of gastric response to agonists and antagonists of acid secretion in fetal rat.
    Garzon B; Ducroc R; Geloso JP
    J Dev Physiol; 1982 Jun; 4(3):195-205. PubMed ID: 7142679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mifentidine, a new H2-antagonist, on pentagastrin-stimulated acid secretion in healthy subjects.
    Lazzaroni M; Ardizzone S; Imbimbo BP; Sangaletti O; Ghirardosi C; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):218-21. PubMed ID: 2884190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study with ranitidine and cimetidine on gastric secretion.
    Sewing KF; Billian A; Malchow H
    Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between mast cells/parietal cells and maximal/basal acid output ratio in chronic gastritis.
    Biernacka D; Muszynski J; Tomaszewska A; Moskalewski S
    Res Exp Med (Berl); 2000 Dec; 200(1):35-41. PubMed ID: 11197920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.